Treatment of sleep dysfunction and psychiatric disorders

Current Treatment Options in Neurology

Volumn 11, Issue 5, 2009, Pages 349-357

  Becker, Philip M ^a   Sattar, Muhammad ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; BENZODIAZEPINE DERIVATIVE; CHLORDIAZEPOXIDE; CLONAZEPAM; CLORAZEPATE; DIAZEPAM; DOXEPIN; ESZOPICLONE; FLUOXETINE; HYPNOTIC SEDATIVE AGENT; IMIPRAMINE; LORAZEPAM; MELATONIN; MIRTAZAPINE; NEFAZODONE; NON PRESCRIPTION DRUG; OXAZEPAM; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; ZALEPLON; ZOLPIDEM;

ADJUVANT THERAPY; ALTERNATIVE MEDICINE; ANXIETY DISORDER; BEDTIME DOSAGE; BEHAVIOR DISORDER; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; CONVULSION; COORDINATION DISORDER; DEPRESSION; DIET THERAPY; DROWSINESS; DRUG CHOICE; DRUG DEPENDENCE; DRUG DOSE REDUCTION; DRUG EFFICACY; FATIGUE; HUMAN; INSOMNIA; LIFESTYLE MODIFICATION; LIVER INJURY; MAJOR DEPRESSION; MEMORY DISORDER; MENTAL DISEASE; MOOD DISORDER; MYALGIA; NEURALGIA; POSTTRAUMATIC STRESS DISORDER; PSYCHOMOTOR DISORDER; PSYCHOPHARMACOTHERAPY; RELAXATION TRAINING; REVIEW; SEDATION; SEIZURE; SIDE EFFECT; SLEEP DISORDER; SLEEP PATTERN; SLEEP RESTRICTION THERAPY; SLEEP TIME; SOMNOLENCE; STIMULUS CONTROL; WEIGHT GAIN; WITHDRAWAL SYNDROME; XEROSTOMIA;

EID: 68949160946     PISSN: 10928480     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11940-009-0039-z     Document Type: Review

References (48)

1. Bassetti CL: Sleep and stroke. Semin Neurol 2005, 25:19-32.
2. Spalletta G, Ripa A, Caltagirone C: Symptom profile of DSM-IV major and minor depressive disorders in first-ever stroke patients. Am J Geriatr Psychiatry 2005, 13:108-115.
3. Chaudhuri KR, Schapira AH: Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment. Lancet Neurol 2009, 8:464-474.
4. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR). Arlington, VA: American Psychiatric Publishing; 2000.
5. Cano G, Mochizuki T, Saper CB: Neural circuitry of stress-induced insomnia in rats. J Neurosci 2008, 28:10167-10184.
6. Ohayon MM, Roth T: Place of chronic insomnia in the course of depressive and anxiety disorders. J Psychiatr Res 2003, 37:9-15.
7. Perlis ML, Smith LJ, Lyness JM, et al.: Insomnia as a risk factor for onset of depression in the elderly. Behav Sleep Med 2006, 4:104-113.
8. Breslau N, Roth T, Rosenthal L, Andreski P: Sleep disturbance and psychiatric disorders: A longitudinal epidemiological study of young adults. Biol Psychiatry 1996, 39:411-418.
9. Ford DE, Kamerow DB: Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? JAMA 1989, 262:1479-1484.
10. Chang PP, Ford DE, Mead LA, et al.: Insomnia in young men and subsequent depression. The Johns Hopkins Precursors Study. Am J Epidemiol 1997, 146:105-114.
11. Bernert RA, Joiner TE Jr, Cukrowicz KC, et al.: Suicidality and sleep disturbances. Sleep 2005, 28:1135-1141.
12. National Institutes of Health: National Institutes of Health State of the Science Conference statement on Manifestations and Management of Chronic Insomnia in Adults, June 13-15,2005. Sleep 2005, 28:1049-1057.
13. Pigeon WR, Hegel M, Unutzer J, et al.: Is insomnia a perpetuating factor for late life depression in the IMPACT cohort? Sleep 2008, 31:482-488.
14. Benca RM: Mood disorders. In Principles and Practices of Sleep Medicine, edn 4. Edited by Kryger M, Roth T, Dement W. Philadelphia: Elsevier; 2005:1311-1326.
15. Lawrence RW: Effect of mirtazapine versus fluoxetine on "sleep quality." J Clin Psychiatry 2004, 65:1149-1150.
16. Nierenberg AA, Keefe BR, Leslie VC, et al.: Residual symptoms in depressed patients who respond acutely to fluoxetine. J Clin Psychiatry 1999, 60:221-225.
17. Calhoun PS, Wiley M, Dennis MF, et al.: Objective evidence of sleep disturbance in women with posttraumatic stress disorder. J Trauma Stress 2007, 20:1009-1018.
18. Kobayashi I, Boarts JM, Delahanty DL: Polysomnographically measured sleep abnormalities in PTSD: A meta-analytic review. Psychophysiology 2007, 44:660-669.
19. Nowell PD, Buysse DJ: Treatment of insomnia in patients with mood disorders. Depress Anxiety 2001, 14:7-18.
20. Jindal RD, Thase ME: Treatment of insomnia associated with clinical depression. Sleep Med Rev 2004, 8:19-30.
21. Smith MT, Perlis ML: Who is a candidate for cognitive-behavioral therapy for insomnia? Health Psychol 2006, 25:15-19.
22. Becker PM: Pharmacologic and nonpharmacologic treatments of insomnia. Neurol Clin 2005, 23:1149-1163.
23. Germain A, Moul DE, Franzen PL, et al.: Effects of a brief behavioral treatment for late-life insomnia: Preliminary findings. J Clin Sleep Med 2006, 2:403-406.
24. Rush AJ, Trivedi MH, Wisniewski SR, et al.: Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N Engl J Med 2006, 354:1231-1242.
25. Bootzin R: Stimulus control treatment for insomnia. Proceedings of the 80th Annual Convention of the American Psychological Association 1972, 7:395-396.
26. Spielman AJ, Saskin P, Thorpy MJ: Treatment of chronic insomnia by restriction of time in bed. Sleep 1987, 10:45-56.
27. Hauri PJ: Sleep hygiene, relaxation therapy, and cognitive interventions. In Case Studies in Insomnia. Edited by Hauri PJ. New York: Plenum Publishing; 1991:65-84.
28. Ong JC, Shapiro SL, Manber R: Combining mindfulness meditation with cognitive-behavior therapy for insomnia: A treatment-development study. Behav Ther 2008, 39:171-182.
29. EspiC CA: Insomnia: conceptual issues in the development, persistence, and treatment of sleep disorder in adults. Annu Rev Psychol 2002, 53:215-243.
30. Lichstein KL, Morin CM (eds): Treatment of Late-Life Insomnia. Thousand Oaks: Sage Publications; 2000.
31. Morin CM, Hauri PJ, Espie CA, et al.: Nonpharmacologic treatment of chronic insomnia. An American Academy of Sleep Medicine review. Sleep 1999, 22:1134-1156.
32. Jacobs GD, Pace-Schott EF, Stickgold R, Otto MW: Cognitive behavior therapy and pharmacotherapy for insomnia: A randomized controlled trial and direct comparison. Arch Intern Med 2004, 164:1888-1896.
33. Rybarczyk B, Stepanski E, Fogg L, et al.: A placebo-controlled test of cognitive-behavioral therapy for comorbid insomnia in older adults. J Consult Clin Psychol 2005, 73:1164-1174.
34. Borbely AA, Youmbi-Balderer G: Effect of diphenhydramine on subjective sleep parameters and on motor activity during bedtime. Int J Clin Pharmacol Ther Toxicol 1988, 26:392-396.
35. Suresh Kumar PN, Andrade C, Bhakta SC, et al.: Melatonin in schizophrenic outpatients with insomnia: A double blind, placebo-controlled study. J Clin Psychiatry 2007, 68:237-241.
36. Mendelson WB: A review of the evidence for the efficacy and safety of trazodone in insomnia. J Clin Psychiatry 2005, 66:469-476.
37. Becker PM: Trazodone as a hypnotic in major depression. Sleep Med 2004, 5:7-8.
38. Ringdahl EN, Pereira SL, Delzell JE Jr: Treatment of primary insomnia. J Am Board Fam Pract 2004, 17:212-219.
39. Papakostas GI, Homberger CH, Fava M: A meta-analysis of clinical trials comparing mirtazapine with selective serotonin reuptake inhibitors for the treatment of major depressive disorder. J Psychopharmacol 2008, 22:843-848.
40. Mendelson WB, Roth T, Cassella J, et al.: The treatment of chronic insomnia: Drug indications, chronic use and abuse liability. Summary of a 2001 New Clinical Drug Evaluation Unit meeting symposium. Sleep Med Rev 2004, 8:7-17.
41. Gross PK, Nourse R, Wasser TE: Ramelteon for insomnia symptoms in a community sample of adults with generalized anxiety disorder: An open label study. J Clin Sleep Med 2009, 5:28-33.
42. Sateia MJ, Nowell PD: Insomnia. Lancet 2004, 364: 1959-1973.
43. Krystal AD, Walsh JK, Laska E, et al.: Sustained efficacy of eszopiclone over 6 months of nightly treatment: Results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia. Sleep 2003, 26:793-799.
44. Barbera J, Shapiro C: Benefit-risk assessment of zaleplon in the treatment of insomnia. Drug Saf 2005, 28:301-318.
45. Perlis ML, McCall WV, Krystal AD, Walsh JK: Long-term, non-nightly administration of zolpidem in the treatment of patients with primary insomnia. J Clin Psychiatry 2004, 65:1128-1137.
46. Smith MT, Perlis ML, Park A, et al.: Comparative metaanalysis of pharmacotherapy and behavior therapy for persistent insomnia. Am J Psychiatry 2002, 159:5-11.
47. Morin CM, Belanger L, Bastien C, Vallières A: Long-term outcome after discontinuation of benzodiazepines for insomnia: A survival analysis of relapse. Behav Res Ther 2005, 43:1-14.
48. Morin CM, Vallières A, Guay B, et al.: Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: A randomized controlled trial. JAMA 2009, 301:2005-2015.